Panacea Life Sciences Holdings, Inc.
PLSH· OTC
Filed Nov 6, 2015 · 10-Q · 37 days after period end · 0001415889-15-003620
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | $0.00 | $213.00 |
| Net Income | -$112.63K | -$74.89K |
| EPS Diluted | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 6, 2015 · 37 d after period end